Malaya Bhattacharya-Chatterjee
Overview
Explore the profile of Malaya Bhattacharya-Chatterjee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
211
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Saha A, Baral R, Chatterjee S, Mohanty K, Pal S, Foon K, et al.
Cancer Immunol Immunother
. 2005 Jul;
55(5):515-27.
PMID: 16044253
A murine monoclonal anti-idiotype (Id) antibody, 3H1 has been developed and characterized previously. Anti-Id 3H1 mimics a specific epitope of carcinoembryonic antigen (CEA) and can be used as a surrogate...
12.
Saha A, Chatterjee S, Foon K, Primus F, Sreedharan S, Mohanty K, et al.
Cancer Res
. 2004 Jul;
64(14):4995-5003.
PMID: 15256474
In this report, we have studied the immunogenicity of the nominal antigen, carcinoembryonic antigen (CEA), and that of an anti-idiotype antibody, 3H1, which mimics CEA and can be used as...
13.
Dasgupta S, Tripathi P, Bhattacharya-Chatterjee M, OMalley Jr B, Chatterjee S
Mol Ther
. 2003 Aug;
8(2):238-48.
PMID: 12907146
We evaluated the efficacy of a replication-competent, attenuated recombinant vaccinia virus (rvv) expressing IL-2 as a tumor vaccine in an immunocompetent murine model of head and neck squamous cell carcinoma....
14.
Saha A, Chatterjee S, Foon K, Primus F, Bhattacharya-Chatterjee M
Cancer Res
. 2003 Jun;
63(11):2844-54.
PMID: 12782590
In this study, using the carcinoembryonic antigen (CEA)-expressing C15 murine colon carcinoma system in syngeneic C57BL/6 mice, we have evaluated the efficacy of bone marrow-derived dendritic cells (DCs) pulsed with...
15.
Baral R, Saha A, Chatterjee S, Foon K, Krieg A, Weiner G, et al.
Cancer Immunol Immunother
. 2003 Apr;
52(5):317-27.
PMID: 12700947
We have developed and characterized a monoclonal anti-idiotype (Id) antibody, designated 3H1, which mimics a specific epitope of carcinoembryonic antigen (CEA) and can be used as a surrogate for CEA....
16.
Bhattacharya-Chatterjee M, Chatterjee S, Foon K
Expert Opin Biol Ther
. 2003 Jan;
2(8):869-81.
PMID: 12517266
The use of anti-idiotype (Id) antibodies as vaccines to stimulate antitumour immunity is one of several promising immunologic approaches to the therapy of cancer. Extensive studies in animal tumour models...